Our new Life Sciences MoFo Perspectives podcast is available now. In this episode, several of our Life Sciences Group partners unpack the science, regulatory framework, commercial transactions, and privacy and data security considerations of applying AI and data science to the fight against COVID-19.
We cover topics such as:
- How are companies using AI and machine learning to combat the COVID-19?
- How might this technology be helpful in predicting the potential spread of COVID-19 or any other virus?
- What are privacy issues involved in contact tracing?
- What kind of government guidelines are being put in place regarding how the data are collected?
- How are companies collaborating to use cloud computing and AI data in the fight against COVID-19?
- What are some of the legal issues companies should be aware of when negotiating deals involving data and AI?
- What are some of the ways the FDA is addressing the use of AI and software in fighting COVID-19?
Listen to our podcast.
Follow our MoFo Life Sciences blog.
A former lead engineer at the NASA Jet Propulsion Laboratory, Dr. Nguyen focuses her practice on domestic and international patent prosecution. She is a founder and co-leader of the firm’s Life Sciences Data Analytics patent group. She applies her experience also from her doctoral studies and her work as a former research scholar to provide portfolio management and counseling, IP due diligence, and freedom-to-operate More ›
Kristen J. Mathews
Kristen is a partner in our Global Privacy + Data Security Group. For more than 20 years, Kristen’s practice has focused on advising clients on the full spectrum of the most complex privacy and cybersecurity issues, including regulatory and compliance matters. An early leader in the privacy sphere, Kristen has developed comprehensive knowledge and long-term perspective, cultivated a client base across a broad range More ›
Matthew A. Karlyn has 23 years of experience in working with companies in the healthcare, pharmaceutical, medical device, and technology industries on a wide range of commercial life sciences, licensing, and technology transactions. His clients range from Fortune 100 companies to start-ups, and he regularly advises companies on matters involving IP commercialization, complex collaboration transactions, licensing initiatives, subscription-based economics, and business transactions related to More ›
Bethany J. Hills
Bethany J. Hills advises her life sciences and health tech industry clients on both pre- and post-market issues, including everything from FDA submissions and communication strategies to post-approval FDA and healthcare compliance and reimbursement issues. Her clients span the full range of FDA and healthcare regulated companies, including medical device and health tech, drug, combination product, diagnostic, biologic, and regenerative medicine, cosmetic, dietary supplement, More ›
Michael R. Ward
Michael R. Ward is global head of the firm’s Life Sciences Practice Group, head of the firm’s Patent Practice Group, co-chair of the firm’s Intellectual Property Practice Group and co-chair of our global AgTech + Food Industry practice.
Dr. Ward is widely recognized as one of the world’s leading agriculture IP lawyers. As the founder and head of the firm’s Plant Intellectual Property Group, Dr. More ›